AC
Armistice Capital Portfolio holdings
AUM
$2.64B
This Quarter Return
+7.03%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$3.77B
AUM Growth
+$3.77B
(+12%)
Cap. Flow
-$39.3M
Cap. Flow
% of AUM
-1.04%
Top 10 Holdings %
Top 10 Hldgs %
28.51%
Holding
375
New
122
Increased
57
Reduced
81
Closed
81
Top Buys
| 1 |
GSK
GSK
|
$70.8M |
| 2 |
Sanofi
SNY
|
$51.5M |
| 3 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$50.9M |
| 4 |
argenx
ARGX
|
$44.9M |
| 5 |
Jazz Pharmaceuticals
JAZZ
|
$41.7M |
Top Sells
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$50.8M |
| 2 |
Incyte
INCY
|
$50.2M |
| 3 |
Keurig Dr Pepper
KDP
|
$45.5M |
| 4 |
UnitedHealth
UNH
|
$36.9M |
| 5 |
SentinelOne
S
|
$36.2M |
Sector Composition
| 1 | Healthcare | 68.31% |
| 2 | Consumer Staples | 10.4% |
| 3 | Consumer Discretionary | 9.57% |
| 4 | Technology | 7.34% |
| 5 | Communication Services | 2.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Orthofix Medical
OFIX
$592M
| $48.5M | 0.66% | 3,600,000 +636,000 | +21% | +$8.57M |
|
27
MacroGenics
MGNX
$112M
| $44M | 0.6% | 4,572,000 -140,000 | -3% | -$1.35M |
|
28
Colgate-Palmolive
CL
$67.9B
| $43M | 0.59% | 539,463 -422,537 | -44% | -$33.7M |
|
29
Novo Nordisk
NVO
$251B
| $41M | 0.56% | 396,000 -40,000 | -9% | -$4.14M |
|
30
Post Holdings
POST
$6.15B
| $40.6M | 0.55% | 461,377 -72,257 | -14% | -$6.36M |
|
31
Vertex Pharmaceuticals
VRTX
$100B
| $39.9M | 0.54% | 98,000 -18,117 | -16% | -$7.37M |
|
32
Treace Medical Concepts
TMCI
$464M
| $36.4M | 0.5% | +2,856,000 | New | +$36.4M |
|
33
Voyager Therapeutics
VYGR
$186M
| $35.8M | 0.49% | 4,236,000 +58,000 | +1% | +$490K |
|
34
DocuSign
DOCU
$15.5B
| $33.8M | 0.46% | 568,000 -135,147 | -19% | -$8.03M |
|
35
Alkermes
ALKS
$4.78B
| $33.3M | 0.45% | 1,200,000 -696,775 | -37% | -$19.3M |
|
36
Kellanova
K
$27.6B
| $32.7M | 0.45% | 585,000 +580,799 | +13,825% | +$32.5M |
|
37
Kraft Heinz
KHC
$33.1B
| $32.4M | 0.44% | 875,556 -415,452 | -32% | -$15.4M |
|
38
Kura Oncology
KURA
$686M
| $32M | 0.44% | 2,224,000 -12,000 | -0.5% | -$173K |
|
39
Xencor
XNCR
$580M
| $31.8M | 0.43% | 1,500,000 +22,000 | +1% | +$467K |
|
40
Constellation Brands
STZ
$28.5B
| $30.9M | 0.42% | +127,868 | New | +$30.9M |
|
41
Toast
TOST
$26.3B
| $30.3M | 0.41% | 1,662,070 +424,711 | +34% | +$7.76M |
|
|
MRTX
42
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $29.4M | 0.4% | 500,000 -864,098 | -63% | -$50.8M |
|
43
Texas Roadhouse
TXRH
$11.5B
| $28.7M | 0.39% | +235,000 | New | +$28.7M |
|
44
SharkNinja
SN
$16.5B
| $28.4M | 0.39% | 555,012 +228,012 | +70% | +$11.7M |
|
|
BCYC
45
Bicycle Therapeutics
BCYC
$511M
| $27.8M | 0.38% | 1,536,000 +536,000 | +54% | +$9.69M |
|
46
Starbucks
SBUX
$100B
| $26.7M | 0.37% | +278,467 | New | +$26.7M |
|
|
47
UnitedHealth
UNH
$281B
| $26.3M | 0.36% | 50,000 -70,000 | -58% | -$36.9M |
|
48
AB InBev
BUD
$122B
| $26.3M | 0.36% | 407,000 -296,000 | -42% | -$19.1M |
|
49
Rigel Pharmaceuticals
RIGL
$697M
| $24.8M | 0.34% | 17,100,000 -36,000 | -0.2% | -$52.2K |
|
|
AUTL
50
Autolus Therapeutics
AUTL
$399M
| $24.8M | 0.34% | 3,850,000 -3,050,000 | -44% | -$19.6M |
|